Adults Over 65 Should Get RSV Shots: CDC Panel
June 22, 2023
Morning Briefing
An advisory committee to the CDC decided Wednesday that newly approved RSV vaccines should be given to all adults ages 65 and over. Meanwhile, in St. Louis, the first mpox case of the year was reported. Other news concerns measles, malaria, extreme heat, and more.
Republicans Seek To Protect Troops Discharged For Refusing Covid Shots
June 22, 2023
Morning Briefing
Military.com reports that the House Armed Services Committee was looking at this matter, and new amendments to the annual policy bill could even see affected troops reinstated. Separately, reports say U.S. intelligence agencies may never find covid’s real origins.
Majority Of OB-GYNs Polled Say Dobbs Had Negative Impact On Maternal Health
June 22, 2023
Morning Briefing
In a KFF survey of 569 board-certified OB-GYNs across the U.S., 68% say the Supreme Court’s reversal of Roe v. Wade has made pregnancy-related medical emergencies worse, while 64% report that the ruling has worsened pregnancy-related mortality.
Florida’s Medicaid Ban On Gender-Affirming Care Blocked In Court
June 22, 2023
Morning Briefing
A federal judge ruled against Florida’s ban for paying for hormone therapy for transgender people on Medicaid: “There is no rational basis for a state to categorically ban these treatments or exclude them from the state’s Medicaid coverage.”
PhRMA Files Lawsuit Challenging Medicare Drug Price Negotiation Law
June 22, 2023
Morning Briefing
The top pharmaceutical lobbying group filed suit against HHS Wednesday in a Texas district court. The move assures that the case will move through the conservative 5th Circuit Court of Appeals.
Morning Briefing for Thursday, June 22, 2023
June 22, 2023
Morning Briefing
Medicare drug price negotiations, transgender care, maternal health, RSV shots, covid vaccines, medical debt, and more are in the news.
First Edition: June 22, 2023
June 22, 2023
Morning Briefing
Today’s early morning highlights from the major news organizations.
Black, Rural Southern Women at Gravest Risk From Pregnancy Miss Out on Maternal Health Aid
By Sarah Jane Tribble
June 22, 2023
KFF Health News Original
A federal program meant to reduce maternal and infant mortality in rural areas isn’t reaching Black women who are most likely to die from pregnancy-related causes.
Farmacéuticas abandonan los genéricos baratos y ahora los pacientes de cáncer en EE.UU. no pueden conseguir medicamentos
By Arthur Allen
June 21, 2023
KFF Health News Original
El cisplatino y el carboplatino son algunos de los medicamentos que escasean, así como otros 12 contra el cáncer, pastillas para el trastorno por déficit de atención con hiperactividad, anticoagulantes y antibióticos.
Study Highlights Estriol As Possible Treatment For Multiple Sclerosis; Covid Vaccine Does Not Affect Fertility
June 21, 2023
Morning Briefing
Read recent pharmaceutical developments in KFF Health News’ Prescription Drug Watch roundup.
Viewpoints: How Is The Overturning Of Roe Holding Up?; Anti-Vaxxers Shouldn’t Be Given Debate Platform
June 21, 2023
Morning Briefing
Editorial writers tackle abortion, anti-vaxxers, covid, and mental health.
California’s Plan For Housing People With Mental Illnesses Unveiled
June 21, 2023
Morning Briefing
California Gov. Gavin Newsom revealed details of a project to build housing for people with mental illness, and addiction. Meanwhile, federal policy to address homelessness is reported as under attack from conservatives.
Many Parents Disregard Their Kids’ Stomach Aches, Poll Finds
June 21, 2023
Morning Briefing
Also in public health news: augmented reality goggles in medicine; heavy drinking; organ transplantation; and more.
Supply Shortages Now Hit Vyvanse, An Alternative To Hard-To-Find Adderall
June 21, 2023
Morning Briefing
Vyvanse, Bloomerg reports, is in low supply due to manufacturing issues, as increased demand caused by shortages of Adderall has hit inventories of the drug. Separately, a spotlight is thrown on the way drugmakers are abandoning cheap generics, which is impacting cancer drug supplies.
US News & World Report Reveals Children’s Hospital Ratings
June 21, 2023
Morning Briefing
The rankings released by U.S. News & World Report have been the subject of recent controversy, and today, new ratings — this time for the country’s top children’s hospitals — have been revealed. USA Today reports San Francisco’s attorney David Chu is investigating the ratings for alleged bias.
1 Of 3 Chinese Scientists Who Fell Ill Early In Covid Was US-Funded
June 21, 2023
Morning Briefing
The illness that 3 Wuhan Institute of Virology researchers suffered during the initial outbreak of covid is “unspecified,” according to the Wall Street Journal. Meanwhile, with new surges of covid expected in the fall, CNBC covers how Pfizer, Moderna and Novavax are gearing-up for the next covid vaccines.
Task Force: Regularly Screen All Adults Under 65 For Anxiety
June 21, 2023
Morning Briefing
All young and middle-age adults should be regularly screened for anxiety and depression, regardless of whether they’re showing symptoms, according to new advice from the U.S. Preventive Services Task Force. Axios, meanwhile, covers stress relief tips that don’t involve exercise.
Naloxone Affordability At Center Of White House Summit With Drugmakers
June 21, 2023
Morning Briefing
Representatives from 10 pharmaceutical companies met with White House officials Tuesday to discuss ways to increase access to overdose-reversal medication amidst the opioid epidemic. Separately, Stat reports that overdoses from xylazine can’t be treated with naloxone.
Morning Briefing for Wednesday, June 21, 2023
June 21, 2023
Morning Briefing
Transgender health care, abortion law, opioid overdoses, anxiety, covid origins, drug shortages, and more are in the news.